Defining the Pharmaceutical System to Support Proactive Drug Safety

E-ISSN： 2212-3911|8|1|25-39

ISSN： 1574-8863

Source： Current Drug Safety, Vol.8, Iss.1, 2013-02, pp. : 25-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety assessment of niacin in the US Food and Drug Administration's mini‐sentinel system

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 1, 2018-01 ,pp. : 30-37

John Wiley & Sons Inc

Access to resources Recommend Favorite

If You Don't Know Where You Are Going, You Can't Tell If You Have Arrived: Defining Goals for Drug Safety Announcements

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 4, 2013-04 ,pp. : 302-303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial (Hot Topic: What can be Done to Improve Confidence and Trust in the Safety of the System for Pharmaceutical Products?)

Current Drug Safety, Vol. 8, Iss. 1, 2013-02 ,pp. : 1-3

Bentham Science Publishers

Access to resources Recommend Favorite

Defining attributes of patient safety through a concept analysis

JOURNAL OF ADVANCED NURSING, Vol. 71, Iss. 11, 2015-11 ,pp. : 2490-2503

John Wiley & Sons Inc

Access to resources Recommend Favorite

Accreditation Essentials: Getting Proactive About Reducing Adverse Events and Safety Risks

Joint Commission: The Source, Vol. 3, Iss. 9, 2005-09 ,pp. : 3-11

Joint Commission Resources

Access to resources Recommend Favorite